CTI BioPharma Corp. (CTIC)
Jun 26, 2023 - CTIC was delisted (reason: acquired by Sobi)
9.09
0.00 (0.00%)
Inactive · Last trade price on Jun 23, 2023

CTI BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Year Ending
TTMDec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash & Equivalents
24.2130.4265.4540.3931.1436.44
Short-Term Investments
34.849.52012.062.5230.6
Cash & Cash Equivalents
59.0179.9465.4552.4533.6767.04
Cash Growth
-39.10%22.14%24.78%55.80%-49.78%55.12%
Receivables
22.9615.3900013.68
Inventory
0.780.730000
Other Current Assets
3.713.342.931.871.911.78
Total Current Assets
86.4599.468.3854.3335.5882.49
Property, Plant & Equipment
000.180.721.241.79
Goodwill and Intangibles
22.7123.230000
Other Long-Term Assets
3.113.33.883.29.475.55
Total Long-Term Assets
25.8226.534.063.9210.77.34
Total Assets
112.27125.9372.4358.2446.2889.83

Liabilities

Year Ending
TTMDec '22 Dec '21 Dec '20 Dec '19 Dec '18
Accounts Payable
2.032.013.891.6404.5
Current Debt
48.0847.9447.384.464.814.81
Other Current Liabilities
18.1231.1815.3810.9513.6813.75
Total Current Liabilities
68.2381.1366.6517.0418.4923.06
Long-Term Debt
68.3761.13004.469.27
Other Long-Term Liabilities
1.021.232.021.175.414.57
Total Long-Term Liabilities
69.3962.372.021.179.8613.84
Total Liabilities
137.62143.568.6718.2128.3536.89

Shareholders' Equity

Year Ending
TTMDec '22 Dec '21 Dec '20 Dec '19 Dec '18
Common Stock
2,5072,5012,4302,3682,2992,294
Retained Earnings
-2,532-2,519-2,426-2,328-2,276-2,225
Comprehensive Income
-0.01-0.04000-10.64
Shareholders' Equity
-25.35-17.583.7740.0323.6958.69

Additional Metrics

Year Ending
TTMDec '22 Dec '21 Dec '20 Dec '19 Dec '18
Total Debt
116.46109.0847.384.469.2714.08
Debt Growth
9.75%130.22%963.52%-51.93%-34.18%0.43%
Net Cash (Debt)
-57.44-29.1418.074824.452.96
Net Cash (Debt) Growth
---62.36%96.71%-53.93%81.37%
Net Cash Per Share
-0.44-0.250.200.670.420.94
Working Capital
18.2318.261.7337.2917.0959.44
Book Value Per Share
-0.19-0.150.040.560.411.05